USPTO serial 77139246
LOVAZA
Reviewed by CopyMark Law Group
Status 601
- Filing date
- Status date
- Registration date
- —
- Examiner
- —
- Law office
- INITIAL REVIEW/SERIALIZATION BRANCH(MAILROOM)
What this means
This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.
Need help with LOVAZA?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Matthew W. Walch
MATTHEW W. WALCH LATHAM & WATKINS LLP233 S WACKER DR STE 5800CHICAGO, IL 60606-6362UNITED STATESGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Pharmaceutical preparations for the treatment of cardiovascular conditions | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Jun 1, 2007 | MAB1 | ABANDONMENT NOTICE MAILED - EXPRESS ABANDONMENT | — |
| Jun 1, 2007 | ABN1 | ABANDONMENT - EXPRESS MAILED | — |
| Jun 1, 2007 | EXAR | TEAS EXPRESS ABANDONMENT RECEIVED | — |
| Mar 28, 2007 | NWAP | NEW APPLICATION ENTERED | — |